HomeDivi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix Innfotainment November 05, 2023 0 A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs http://dlvr.it/SyPZCW Newer Older
